These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 20947538)

  • 1. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study.
    Drechsler C; Verduijn M; Pilz S; Dekker FW; Krediet RT; Ritz E; Wanner C; Boeschoten EW; Brandenburg V;
    Nephrol Dial Transplant; 2011 Mar; 26(3):1024-32. PubMed ID: 20947538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D status and mortality in chronic kidney disease.
    Pilz S; Tomaschitz A; Friedl C; Amrein K; Drechsler C; Ritz E; Boehm BO; Grammer TB; März W
    Nephrol Dial Transplant; 2011 Nov; 26(11):3603-9. PubMed ID: 21378153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men.
    Lee DM; Vanderschueren D; Boonen S; O'Neill TW; Pendleton N; Pye SR; Ravindrarajah R; Gielen E; Claessens F; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Punab M; Wu FC;
    Age Ageing; 2014 Jul; 43(4):528-35. PubMed ID: 24375224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor agonist supplementation and suppression of inflammation may have advantage for all-cause mortality in hemodialysis patients.
    Ogawa T; Kyono A; Sato M; Sugimoto H; Otsuka K; Nitta K
    Clin Exp Nephrol; 2012 Oct; 16(5):779-85. PubMed ID: 22457088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.
    Nakano C; Hamano T; Fujii N; Obi Y; Matsui I; Tomida K; Mikami S; Inoue K; Shimomura A; Nagasawa Y; Okada N; Tsubakihara Y; Rakugi H; Isaka Y
    Bone; 2012 Jun; 50(6):1266-74. PubMed ID: 22425694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D levels and early mortality among incident hemodialysis patients.
    Wolf M; Shah A; Gutierrez O; Ankers E; Monroy M; Tamez H; Steele D; Chang Y; Camargo CA; Tonelli M; Thadhani R
    Kidney Int; 2007 Oct; 72(8):1004-13. PubMed ID: 17687259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients.
    Drechsler C; Pilz S; Obermayer-Pietsch B; Verduijn M; Tomaschitz A; Krane V; Espe K; Dekker F; Brandenburg V; März W; Ritz E; Wanner C
    Eur Heart J; 2010 Sep; 31(18):2253-61. PubMed ID: 20688781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D status and mortality risk among patients on dialysis: a systematic review and meta-analysis of observational studies.
    Zhang Y; Darssan D; Pascoe EM; Johnson DW; Pi H; Dong J
    Nephrol Dial Transplant; 2018 Oct; 33(10):1742-1751. PubMed ID: 29481620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies.
    Pilz S; Iodice S; Zittermann A; Grant WB; Gandini S
    Am J Kidney Dis; 2011 Sep; 58(3):374-82. PubMed ID: 21636193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of 25-hydroxivitamin D entirely explained by a higher comorbidity burden: experience from a South-Eastern European Dialysis Cohort.
    Schiller A; Apetrii M; Onofriescu M; Siriopol D; Veisa G; Schiller O; Bob F; Timar R; Mihaescu A; Kanbay M; Covic A
    Hemodial Int; 2015 Apr; 19(2):249-55. PubMed ID: 25251168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
    Ginde AA; Scragg R; Schwartz RS; Camargo CA
    J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D, PTH and the risk of overall and disease-specific mortality: Results of the Longitudinal Aging Study Amsterdam.
    El Hilali J; de Koning EJ; van Ballegooijen AJ; Lips P; Sohl E; van Marwijk HWJ; Visser M; van Schoor NM
    J Steroid Biochem Mol Biol; 2016 Nov; 164():386-394. PubMed ID: 26678328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of low free testosterone and low vitamin D predicts mortality in older men referred for coronary angiography.
    Lerchbaum E; Pilz S; Boehm BO; Grammer TB; Obermayer-Pietsch B; März W
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):475-83. PubMed ID: 22356136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
    Schmutz EA; Zimmermann MB; Rohrmann S
    Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study.
    Drechsler C; Evenepoel P; Vervloet MG; Wanner C; Ketteler M; Marx N; Floege J; Dekker FW; Brandenburg VM;
    Nephrol Dial Transplant; 2015 Feb; 30(2):288-93. PubMed ID: 25248363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone alkaline phosphatase and mortality in dialysis patients.
    Drechsler C; Verduijn M; Pilz S; Krediet RT; Dekker FW; Wanner C; Ketteler M; Boeschoten EW; Brandenburg V;
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1752-9. PubMed ID: 21597029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
    Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
    Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study.
    Wang AY; Lam CW; Sanderson JE; Wang M; Chan IH; Lui SF; Sea MM; Woo J
    Am J Clin Nutr; 2008 Jun; 87(6):1631-8. PubMed ID: 18541550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.